Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07174622 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation

Study acronym: SPYRAL CARE
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Re-verified, no change to tracked fieldsv7
  2. Minor Eligibility criteria shortened, about 15 wordsv6 See this version in full on ClinicalTrials.gov ↗
  3. Minor Eligibility criteria shortened, about 7 wordsv5 See this version in full on ClinicalTrials.gov ↗
  4. Notable Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Oct 31, 2025 to Oct 28, 2025 · Site details revisedv4 Show 2 more changesShow less
    • Start date changed from estimate of Oct 31, 2025 to Oct 28, 2025
    • Site details revised
  5. Minor Start date: Oct 8, 2025 to Oct 31, 2025v3
  6. Minor Re-verified, no change to tracked fieldsv2
  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This observational study will assess the long-term effectiveness of the RDN procedure for lowering blood pressure in Medicare patients with uncontrolled hypertension. This research will be conducted using de-identified electronic health records (EHR) and administrative health insurance claims data. Patients are enrolled through the submission of claims or encounter data to CMS.
Trial Details
NCT Number NCT07174622
Lead Sponsor Medtronic Vascular
Conditions Hypertension, Cardiovascular Diseases, Vascular Diseases
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov